ClinicalTrials.Veeva

Menu

Antiseptic Use and Dressing Application

M

Maternite Regionale Universitaire

Status and phase

Completed
Phase 4

Conditions

Skin Colonization
Bacterial Infection
Catheterization

Treatments

Procedure: disinfection efficacy using Amukin
Procedure: disinfection efficacy using Biseptine

Study type

Interventional

Funder types

Other

Identifiers

NCT00389558
MRAP190406

Details and patient eligibility

About

The purposes of the study are:

  1. To compare the local efficacy (skin colonization) of 2 commercialized antiseptics used for the disinfection of the dressing application for an epicutaneocavous catheter (EPI).
  2. To evaluate whether the bacteria responsible for nosocomial infection is comparable to the flora diagnosed at the EPI site.

Full description

Epicutaneocavous catheter is a significant risk factor for nosocomial infection in newborn infants. These infections have been related to local bacterial colonisation. Therefore thorough disinfection should lower the risk of nosocomial infection. However, the local efficacy of antiseptic use has not yet been clearly evaluated in this situation.

Enrollment

453 patients

Sex

All

Ages

Under 3 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All infants admitted to the Neonatal Intensive Care Unit
  • Epicutaneocavous catheter insertion indication

Exclusion criteria

  • Epicutaneocavous catheter not inserted within the Unit

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

453 participants in 2 patient groups

2
Active Comparator group
Description:
Biseptine
Treatment:
Procedure: disinfection efficacy using Biseptine
1
Active Comparator group
Description:
Amukin
Treatment:
Procedure: disinfection efficacy using Amukin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems